In vivo inhibition of angiotensin converting enzyme and neutral endopeptidase by a dual vasopeptidase inhibitor

被引：0
|
作者：
Burrell, LM
Rockell, MD
Powell, J
Johnston, CI
机构：
[1] Bristol Myers Squibb, Princeton, NJ USA
[2] Univ Melbourne, Dept Med, Melbourne, Vic, Australia
来源：
AMERICAN JOURNAL OF HYPERTENSION | 1999年 / 12卷 / 04期
关键词：
vasopeptidase inhibitors; omapatrilat; angiotensin; natriuretic peptides;
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：119A / 119A
页数：1
相关论文
共 50 条
  • [41] Mechanism of vasopeptidase inhibitor-induced plasma extravasation: Comparison of omapatrilat and the novel neutral endopeptidase 24.11/angiotensin-converting enzyme inhibitor GW796406
    Sulpizio, AC
    Pullen, MA
    Edwards, RM
    Louttit, JB
    West, R
    Brooks, DP
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 315 (03): : 1306 - 1313
  • [42] Combined inhibition of neutral endopeptidase and angiotensin-converting enzyme by sampatrilat in essential hypertension
    Wallis, EJ
    Ramsay, LE
    Hettiarachchi, J
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 64 (04) : 439 - 449
  • [43] Sustained antihypertensive actions of a dual angiotensin-converting enzyme neutral endopeptidase inhibitor, sampatrilat, in black hypertensive subjects
    Norton, GR
    Woodiwiss, AJ
    Hartford, C
    Trifunovic, B
    Middlemost, S
    Lee, A
    Allen, MJ
    AMERICAN JOURNAL OF HYPERTENSION, 1999, 12 (06) : 563 - 571
  • [44] Efficient large scale preparation of neutral endopeptidase/angiotensin-converting enzyme dual inhibitor CGS30440
    Johnson, EP
    Cantrell, WR
    Jenson, TM
    Miller, SA
    Parker, DJ
    Reel, NM
    Sylvester, LG
    Szendroi, RJ
    Vargas, KJ
    Xu, J
    Carlson, JA
    ORGANIC PROCESS RESEARCH & DEVELOPMENT, 1998, 2 (04) : 238 - 244
  • [45] Reversal of cardiac hypertrophy and fibrosis by S21402, a dual inhibitor of neutral endopeptidase and angiotensin converting enzyme in SHRs
    Farina, NK
    Johnston, CI
    Burrell, LM
    JOURNAL OF HYPERTENSION, 2000, 18 (06) : 749 - 755
  • [46] Chronic dual inhibition of angiotensin-converting enzyme and neutral endopeptidase during the development of left ventricular dysfunction in dogs
    Thomas, CV
    McDaniel, GM
    Holzgrefe, HH
    Mukherjee, R
    Hird, RB
    Walker, JD
    Hebbar, L
    Powell, JR
    Spinale, FG
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1998, 32 (06) : 902 - 912
  • [47] DUAL INHIBITION OF NEUTRAL ENDOPEPTIDASE AND ANGIOTENSIN-CONVERTING ENZYME BY N-PHOSPHONOMETHYL AND N-CARBOXYALKYL DIPEPTIDES
    DELOMBAERT, S
    TAN, J
    STAMFORD, LJ
    SAKANE, Y
    BERRY, C
    GHAI, RD
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1994, 4 (22) : 2715 - 2720
  • [48] Dual neutral endopeptidase (NEP) Angiotensin Converting Enzyme (ACE) inhibition is biologically different from ACE inhibition, at the same level of ACE inhibition
    Massien, C
    Azizi, M
    Guyene, TT
    Ménard, J
    JOURNAL OF HYPERTENSION, 1998, 16 : S235 - S235
  • [49] Mercaptoacyl dipeptides as orally active dual inhibitors of angiotensin-converting enzyme and neutral endopeptidase
    Fink, CA
    Carlson, JE
    McTaggart, PA
    Qiao, Y
    Webb, R
    Chatelain, R
    Jeng, AY
    Trapani, AJ
    JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (16) : 3158 - 3168
  • [50] NEUTRAL ENDOPEPTIDASE VERSUS ANGIOTENSIN-CONVERTING ENZYME-INHIBITION IN ESSENTIAL-HYPERTENSION
    FAVRAT, B
    BURNIER, M
    NUSSBERGER, J
    LECOMTE, JM
    BROUARD, R
    WAEBER, B
    BRUNNER, HR
    JOURNAL OF HYPERTENSION, 1995, 13 (07) : 797 - 804
12345